SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. Its lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York. Show more

Location: 31 East 62nd Street, New York, NY, 10065, United States | Website: https://www.siga.com | Industry: Drug Manufacturers - Specialty & Generic | Sector: Healthcare


Market Cap

616.5M

52 Wk Range

$4.95 - $9.62

Previous Close

$8.61

Open

$8.55

Volume

545,020

Day Range

$8.34 - $8.58

Enterprise Value

434.3M

Cash

182.5M

Avg Qtr Burn

N/A

Insider Ownership

43.24%

Institutional Own.

50.20%

Qtr Updated

06/30/25